- Home
- ALZN vs ATNF Comparison
ALZN vs ATNF Comparison
Compare ALZN & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ATNF
- Stock Information
- Founded
- ALZN 2016
- ATNF 2016
- Country
- ALZN United States
- ATNF United States
- Employees
- ALZN N/A
- ATNF N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- ALZN Health Care
- ATNF Health Care
- Exchange
- ALZN Nasdaq
- ATNF Nasdaq
- Market Cap
- ALZN 4.5M
- ATNF 3.8M
- IPO Year
- ALZN 2021
- ATNF N/A
- Fundamental
- Price
- ALZN $3.62
- ATNF $1.05
- Analyst Decision
- ALZN Strong Buy
- ATNF
- Analyst Count
- ALZN 1
- ATNF 0
- Target Price
- ALZN $180.00
- ATNF N/A
- AVG Volume (30 Days)
- ALZN 4.6M
- ATNF 42.9K
- Earning Date
- ALZN 07-29-2025
- ATNF 05-15-2025
- Dividend Yield
- ALZN N/A
- ATNF N/A
- EPS Growth
- ALZN N/A
- ATNF N/A
- EPS
- ALZN N/A
- ATNF N/A
- Revenue
- ALZN N/A
- ATNF N/A
- Revenue This Year
- ALZN $322.64
- ATNF N/A
- Revenue Next Year
- ALZN N/A
- ATNF N/A
- P/E Ratio
- ALZN N/A
- ATNF N/A
- Revenue Growth
- ALZN N/A
- ATNF N/A
- 52 Week Low
- ALZN $3.06
- ATNF $0.66
- 52 Week High
- ALZN $135.54
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- ALZN 42.05
- ATNF 49.77
- Support Level
- ALZN $3.55
- ATNF $1.01
- Resistance Level
- ALZN $4.30
- ATNF $1.10
- Average True Range (ATR)
- ALZN 0.58
- ATNF 0.08
- MACD
- ALZN 0.11
- ATNF -0.01
- Stochastic Oscillator
- ALZN 7.44
- ATNF 35.29
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.